{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:13:14Z","timestamp":1789456394432,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00228-026-04165-w","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T05:37:42Z","timestamp":1786513062000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patients\u2019 informational needs regarding adverse drug reactions, and how this information should be provided: a mixed-methods study"],"prefix":"10.1007","volume":"82","author":[{"given":"Richelle L.","family":"Goes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jette A.","family":"van Lint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart J. F.","family":"van den Bemt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi T.","family":"Jessurun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen R.","family":"Gosselt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"4165_CR1","unstructured":"RIVM Chronische Ziekten. Available from: https:\/\/www.rivm.nl\/rivm\/kennis-en-kunde\/expertisevelden\/chronische-ziekten. Accessed 2 Feb 2025"},{"issue":"1","key":"4165_CR2","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.mayocpiqo.2023.08.005","volume":"8","author":"K Hacker","year":"2024","unstructured":"Hacker K (2024) The Burden of Chronic Disease. Mayo Clin Proc Inn Qual Out 8(1):112\u2013119. https:\/\/doi.org\/10.1016\/j.mayocpiqo.2023.08.005","journal-title":"Mayo Clin Proc Inn Qual Out"},{"key":"4165_CR3","doi-asserted-by":"publisher","unstructured":"Quik JM, Gosselt HR, van Lint JA, Kosse LJ, ten Klooster PM, Vonkeman HE et al (2024) The burden of adverse drug reactions reported by patients in the Dutch ADR monitor: a proof of concept. Expert Opin Drug Saf 1\u201311. https:\/\/doi.org\/10.1080\/14740338.2024.2383707","DOI":"10.1080\/14740338.2024.2383707"},{"issue":"5","key":"4165_CR4","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1080\/14740338.2023.2134344","volume":"22","author":"HJ Westerink","year":"2023","unstructured":"Westerink HJ, Kosse LJ, Jessurun NT, van Tubergen A, Vonkeman HE, Nurmohamed MT et al (2023) Patients\u2019 and health-care professionals\u2019 perspectives on adverse drug reaction burden attributed to the use of biological DMARDs: a qualitative study. Expert Opi Drug Saf 22(5):417\u2013424. https:\/\/doi.org\/10.1080\/14740338.2023.2134344","journal-title":"Expert Opi Drug Saf"},{"issue":"sup1","key":"4165_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1517\/14740338.2014.947260","volume":"13","author":"C Leporini","year":"2014","unstructured":"Leporini C, De Sarro G, Russo E (2014) Adherence to therapy and adverse drug reactions: is there a link? Expert Opin Drug Saf 13(sup1):41\u201355. https:\/\/doi.org\/10.1517\/14740338.2014.947260","journal-title":"Expert Opin Drug Saf"},{"key":"4165_CR6","doi-asserted-by":"publisher","unstructured":"Chisholm-Burns MA, Spivey CA (2012) The \u2018cost\u2019 of medication nonadherence: Consequences we cannot afford to accept. Jour Am Pharm Assoc 52(6):823\u2013826. https:\/\/doi.org\/10.1331\/JAPhA.2012.11088","DOI":"10.1331\/JAPhA.2012.11088"},{"issue":"3","key":"4165_CR7","doi-asserted-by":"publisher","first-page":"762","DOI":"10.4081\/jphr.2016.762","volume":"5","author":"L N\u00e1fr\u00e1di","year":"2016","unstructured":"N\u00e1fr\u00e1di L, Galimberti E, Nakamoto K, Schulz PJ (2016) Intentional and Unintentional Medication Non-Adherence in Hypertension: The Role of Health Literacy, Empowerment and Medication Beliefs. J Public Health Res 5(3):762. https:\/\/doi.org\/10.4081\/jphr.2016.762","journal-title":"J Public Health Res"},{"key":"4165_CR8","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.2147\/PPA.S173651","volume":"12","author":"MK Kusch","year":"2018","unstructured":"Kusch MK, Haefeli WE, Seidling HM (2018) How to meet patients\u2019 individual needs for drug information: a scoping review. Patient Prefer Adher 12:2339\u20132355. https:\/\/doi.org\/10.2147\/PPA.S173651","journal-title":"Patient Prefer Adher"},{"issue":"8","key":"4165_CR9","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1080\/14740338.2020.1781090","volume":"19","author":"LJ Kosse","year":"2020","unstructured":"Kosse LJ, Weits G, Vonkeman HE, Spuls PI, van den Bemt BJF, Tas SW et al (2020) Immune-mediated inflammatory disease patients\u2019 preferences in adverse drug reaction information regarding biologics. Expert Opi Drug Saf 19(8):1049\u20131054. https:\/\/doi.org\/10.1080\/14740338.2020.1781090","journal-title":"Expert Opi Drug Saf"},{"issue":"6","key":"4165_CR10","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.sapharm.2016.10.006","volume":"13","author":"A Young","year":"2017","unstructured":"Young A, Tordoff J, Smith A (2017) What do patients want?\u2019 Tailoring medicines information to meet patients\u2019 needs. Res Soc Adm Pharm 13(6):1186\u20131190. https:\/\/doi.org\/10.1016\/j.sapharm.2016.10.006","journal-title":"Res Soc Adm Pharm"},{"issue":"3","key":"4165_CR11","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1369-7625.2011.00665.x","volume":"15","author":"M Garner","year":"2012","unstructured":"Garner M, Ning Z, Francis J (2012) A framework for the evaluation of patient information leaflets. Health Expect 15(3):283\u2013294. https:\/\/doi.org\/10.1111\/j.1369-7625.2011.00665.x","journal-title":"Health Expect"},{"issue":"9","key":"4165_CR12","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1258\/jrsm.2008.080149","volume":"101","author":"A Colledge","year":"2008","unstructured":"Colledge A, Car J, Donnelly A, Majeed A (2008) Health information for patients: time to look beyond patient information leaflets. J R Soc Med 101(9):447\u2013453. https:\/\/doi.org\/10.1258\/jrsm.2008.080149","journal-title":"J R Soc Med"},{"key":"4165_CR13","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s40264-016-0422-0","volume":"39","author":"L Rolfes","year":"2016","unstructured":"Rolfes L, van Hunsel F, Taxis K, van Puijenbroek E (2016) The Impact of Experiencing Adverse Drug Reactions on the Patient\u2019s Quality of Life: A Retrospective Cross-Sectional Study in the Netherlands. Drug Saf 39:769\u2013776. https:\/\/doi.org\/10.1007\/s40264-016-0422-0","journal-title":"Drug Saf"},{"key":"4165_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1080\/10810730.2012.713442","volume":"17","author":"L Squiers","year":"2012","unstructured":"Squiers L, Peinado S, Berkman N, Boudewyns V, McCormack L (2012) The Health Literacy Skills Framework. J Health Commun 17:30\u201354. https:\/\/doi.org\/10.1080\/10810730.2012.713442","journal-title":"J Health Commun"},{"key":"4165_CR15","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s40264-023-01343-y","volume":"46","author":"JA Van Lint","year":"2023","unstructured":"Van Lint JA, Sonnenberg M, Vonkeman HE, van den Bemt BJF, van Puijenbroek EP, Jessurun NT (2023) Development of a Framework Structuring Themes in the Course of Adverse Drug Reactions from a Patient\u2019s Perspective. Drug Saf 46:1039\u20131047. https:\/\/doi.org\/10.1007\/s40264-023-01343-y","journal-title":"Drug Saf"},{"issue":"2","key":"4165_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V (2006) Using thematic analysis in psychology. Qual Res Psychol 3(2):77\u2013101. https:\/\/doi.org\/10.1191\/1478088706qp063oa","journal-title":"Qual Res Psychol"},{"issue":"3","key":"4165_CR17","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1177\/0049124113500475","volume":"42","author":"JL Campbell","year":"2013","unstructured":"Campbell JL, Quincy C, Osserman J, Pedersen OK (2013) Coding In-depth Semistructured Interviews: Problems of Unitization and Intercoder Reliability and Agreement. Sociol Method Res 42(3):294\u2013320. https:\/\/doi.org\/10.1177\/0049124113500475","journal-title":"Sociol Method Res"},{"key":"4165_CR18","doi-asserted-by":"publisher","first-page":"103970","DOI":"10.1016\/j.ijmedinf.2019.103970","volume":"133","author":"MKP Kusch","year":"2020","unstructured":"Kusch MKP, Zien A, Hachenberg C, Haefeli WE, Seidling HM (2020) Information on adverse drug reactions\u2014Proof of principle for a structured database that allows customization of drug information. Int J Med Inf 133:103970. https:\/\/doi.org\/10.1016\/j.ijmedinf.2019.103970","journal-title":"Int J Med Inf"},{"key":"4165_CR19","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00766-024-00426-1","volume":"29","author":"AA Khalil","year":"2024","unstructured":"Khalil AA, Gaol FL, Sabarguna BS, Prabowo H (2024) Navigating personalized medication: unveiling user needs to forge a cutting-edge platform for proactive prevention and monitoring of adverse drug reactions. Requir Eng 29:357\u2013369. https:\/\/doi.org\/10.1007\/s00766-024-00426-1","journal-title":"Requir Eng"},{"key":"4165_CR20","doi-asserted-by":"publisher","first-page":"107921","DOI":"10.1016\/j.pec.2023.107921","volume":"115","author":"S Wilkes","year":"2023","unstructured":"Wilkes S, van der Sijs H, van der Sman E, van der Kuy H, Zaal R (2023) Inpatients\u2019 information needs about medication: A narrative systematic literature review. Patient Educ Couns 115:107921. https:\/\/doi.org\/10.1016\/j.pec.2023.107921","journal-title":"Patient Educ Couns"},{"key":"4165_CR21","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1007\/s11096-020-01125-x","volume":"42","author":"CL Bekker","year":"2020","unstructured":"Bekker CL, Mohsenian Naghani S, Natsch S, Wartenberg NS, van den Bemt BJF (2020) Information needs and patient perceptions of the quality of medication information available in hospitals: a mixed method study. Int J Clin Pharm 42:1396\u20131404. https:\/\/doi.org\/10.1007\/s11096-020-01125-x","journal-title":"Int J Clin Pharm"},{"key":"4165_CR22","doi-asserted-by":"publisher","unstructured":"Medina-C\u00f3rdoba M, Cadavid S, P\u00e9rez-Acosta AM, Amaya-Giraldo V (2021) Factors that Facilitate and Hinder the Comprehension of Patient Information Leaflets (PILs): A Brief Scoping Review. Front Pharmacol 12:Art740334. https:\/\/doi.org\/10.3389\/fphar.2021.740334","DOI":"10.3389\/fphar.2021.740334"},{"key":"4165_CR23","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1186\/s12889-023-15346-y","volume":"23","author":"M Al Jeraisy","year":"2023","unstructured":"Al Jeraisy M, Alshammari H, Albassam M, Al Aamer K, Abolfotouh MA (2023) Utility of patient information leaflet and perceived impact of its use on medication adherence. BMC Public Health 23:488. https:\/\/doi.org\/10.1186\/s12889-023-15346-y","journal-title":"BMC Public Health"},{"key":"4165_CR24","doi-asserted-by":"publisher","first-page":"100171","DOI":"10.1016\/j.pecinn.2023.100171","volume":"2","author":"S Madanian","year":"2023","unstructured":"Madanian S, Nakarada-Kordic I, Reay S, Chetty T (2023) Patients\u2019 perspectives on digital health tools. PEC Innov 2:100171. https:\/\/doi.org\/10.1016\/j.pecinn.2023.100171","journal-title":"PEC Innov"},{"issue":"10","key":"4165_CR25","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/j.jval.2023.06.008","volume":"26","author":"M Haig","year":"2023","unstructured":"Haig M, Main C, Ch\u00e1vez D, Kanavos P (2023) A Value Framework to Assess Patient-Facing Digital Health Technologies That Aim to Improve Chronic Disease Management: A Delphi Approach. Value Health 26(10):1474\u20131484. https:\/\/doi.org\/10.1016\/j.jval.2023.06.008","journal-title":"Value Health"},{"key":"4165_CR26","unstructured":"European Medicines Agency Electronic Product information. Available from: https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/marketing-authorisation\/product-information-requirements\/electronic-product-information-epi. Accessed 19 Jun 2026"},{"issue":"1","key":"4165_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1308\/003588413X13511609956372","volume":"95","author":"TL Jones","year":"2013","unstructured":"Jones TL, Baxter MAJ, Khanduja V (2013) A quick guide to survey research. Ann R Coll Surg Engl 95(1):5\u20137. https:\/\/doi.org\/10.1308\/003588413X13511609956372","journal-title":"Ann R Coll Surg Engl"},{"issue":"1","key":"4165_CR28","doi-asserted-by":"publisher","first-page":"Art5","DOI":"10.7771\/2159-6670.1160","volume":"7","author":"S Rice","year":"2017","unstructured":"Rice S, Winter SR, Doherty S, Milner M (2017) Advantages and Disadvantages of Using Internet-Based Survey Methods in Aviation-Related Research. J Aviat Technol Eng 7(1):Art5. https:\/\/doi.org\/10.7771\/2159-6670.1160","journal-title":"J Aviat Technol Eng"},{"key":"4165_CR29","unstructured":"European Medicines Agency (2025) How to prepare and review a summary of product characteristics. Available from: https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/marketing-authorisation\/product-information-requirements\/how-prepare-review-summary-product-characteristics"},{"key":"4165_CR30","unstructured":"College ter Beoordeling van Geneesmiddelen MEB 27: Toelichting van het College op de \u2018Guideline on Summary of Product Characteristics\u2019. Available from: https:\/\/www.cbg-meb.nl\/onderwerpen\/hv-smpc\/documenten\/beleidsdocumenten\/2023\/01\/01\/meb-27. Accessed 13 May 2025"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04165-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-026-04165-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04165-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:47:25Z","timestamp":1789454845000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-026-04165-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["4165"],"URL":"https:\/\/doi.org\/10.1007\/s00228-026-04165-w","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"assertion":[{"value":"2 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided digital informed consent before starting the survey, and all information was anonymized.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"231"}}